Evaluating the effects of PRISMA on mental health in pretrial detainees
The Short-term Effects of PRISMA on Mental Health
This study is testing a new therapy program called PRISMA to see if it can help improve the mental health of people held in pretrial detention.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1480 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Trial ID | NCT06197711 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to assess the impact of the PRISMA intervention, a cognitive-behavioral therapy-based program, on the mental health of individuals in pretrial detention. Conducted in 11 facilities across the cantons of Zurich and Bern, the study will involve a randomized controlled trial with approximately 5,100 pretrial detainees. The goal is to improve psychological wellbeing and social integration for inmates, particularly those experiencing anxiety, depression, and suicidal ideation. Participants will be randomly assigned to receive either the PRISMA intervention or standard care.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older entering pretrial detention in the specified facilities.
Not a fit: Patients who are not fluent in any of the nine languages offered for PRISMA or those experiencing acute suicidality may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve mental health outcomes for pretrial detainees, reducing anxiety and depression.
How similar studies have performed: Other studies have shown promising results with cognitive-behavioral therapy interventions in similar populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Entering pretrial detention inmate in any of the 11 pretrial detention facilities in the Cantons of Zurich and Bern * aged ≥ 18 years Exclusion Criteria: * Not fluently speaking any of the nine languages in which PRISMA is offered: German, Albanian, Arabic, English, French, Italian, Romanian, Serbian/ Croatian, Spanish * Acute suicidality * Not interested in PRISMA and its randomized evaluation
Where this trial is running
Zurich, Canton of Zurich
- University Hospital Zurich — Zurich, Canton of Zurich, Switzerland (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.